Terms: = Gastric cancer AND BCL10, CIPER, 8915, ENSG00000142867, c-E10, CARMEN, mE10, CLAP AND Treatment
13 results:
1. First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma.
Kuo SH; Yeh KH; Wu MS; Lin CW; Wei MF; Liou JM; Wang HP; Chen LT; Cheng AL
Sci Rep; 2017 Oct; 7(1):14333. PubMed ID: 29084984
[TBL] [Abstract] [Full Text] [Related]
2. Antisecretory medication is associated with decreased Helicobacter pylori detection in gastric marginal zone lymphoma.
Schaberg KB; Evans MF; Wilcox R; Lewis MR
Ann Diagn Pathol; 2015 Dec; 19(6):397-402. PubMed ID: 26615705
[TBL] [Abstract] [Full Text] [Related]
3. bcl10 aberations and NF-kappa B activation involving p65 are absent or rare in primary gastric MALT lymphoma.
Hajder J; Marisavljević D; Stanisavljević N; Mihaljević B; Kovcin V; Marković O; Zivković R
Vojnosanit Pregl; 2014 Nov; 71(11):1040-4. PubMed ID: 25536807
[TBL] [Abstract] [Full Text] [Related]
4. gastric mucosa-associated lymphoid tissue lymphomas and Helicobacter pylori infection: a Colombian perspective.
Yepes S; Torres MM; Saavedra C; Andrade R
World J Gastroenterol; 2012 Feb; 18(7):685-91. PubMed ID: 22363141
[TBL] [Abstract] [Full Text] [Related]
5. [Crucial roles of Helicobacter pylori infection in the pathogenesis of gastric cancer and gastric mucosa-associated lymphoid tissue (MALT) lymphoma].
Ota H; Asano N; Yamauchi K; Akamatsu T
Rinsho Byori; 2009 Sep; 57(9):861-9. PubMed ID: 19860212
[TBL] [Abstract] [Full Text] [Related]
6. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.
Sumida T; Kitadai Y; Hiyama T; Shinagawa K; Tanaka M; Kodama M; Masuda H; Ito M; Tanaka S; Yoshihara M; Chayama K
Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974
[TBL] [Abstract] [Full Text] [Related]
7. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment.
Nakamura S; Matsumoto T; Ye H; Nakamura S; Suekane H; Matsumoto H; Yao T; Tsuneyoshi M; Du MQ; Iida M
Cancer; 2006 Dec; 107(12):2770-8. PubMed ID: 17099876
[TBL] [Abstract] [Full Text] [Related]
8. Update: gastric MALT lymphoma.
Kahl BS
Curr Opin Oncol; 2003 Sep; 15(5):347-52. PubMed ID: 12960515
[TBL] [Abstract] [Full Text] [Related]
9. Etiology and therapy of Helicobacter pylori-associated gastric lymphomas.
Wündisch T; Kim TD; Thiede C; Morgner A; Alpen B; Stolte M; Neubauer A
Ann Hematol; 2003 Sep; 82(9):535-45. PubMed ID: 12845479
[TBL] [Abstract] [Full Text] [Related]
10. High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma.
Ye H; Liu H; Raderer M; Chott A; Ruskone-Fourmestraux A; Wotherspoon A; Dyer MJ; Chuang SS; Dogan A; Isaacson PG; Du MQ
Blood; 2003 Apr; 101(7):2547-50. PubMed ID: 12517817
[TBL] [Abstract] [Full Text] [Related]
11. gastric lymphoma: the revolution of the past decade.
Boot H; de Jong D
Scand J Gastroenterol Suppl; 2002; (236):27-36. PubMed ID: 12408501
[TBL] [Abstract] [Full Text] [Related]
12. gastric MALT lymphoma: from aetiology to treatment.
Du MQ; Isaccson PG
Lancet Oncol; 2002 Feb; 3(2):97-104. PubMed ID: 11902529
[TBL] [Abstract] [Full Text] [Related]
13. treatment of follicular and other indolent lymphomas.
McLaughlin P
Curr Opin Oncol; 1999 Sep; 11(5):333-8. PubMed ID: 10505768
[TBL] [Abstract] [Full Text] [Related]
